federal_register: 2011-5945

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2011-5945 Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims; Availability Notice The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims." This guidance is intended to assist applicants in developing labeling for outcome claims for drugs that are indicated to treat hypertension. With few exceptions, current labeling for antihypertensive drugs includes only the information that these drugs are indicated to reduce blood pressure; the labeling does not include information on the clinical benefits related to cardiovascular outcomes expected from such blood pressure reduction. However, blood pressure control is well established as beneficial in preventing serious cardiovascular events, and inadequate treatment of hypertension is acknowledged as a significant public health problem. The Agency believes that the appropriate use of these drugs can be encouraged by making the connection between lower blood pressure and improved cardiovascular outcomes more explicit in labeling. 2011-03-15 2011 3 https://www.federalregister.gov/documents/2011/03/15/2011-5945/guidance-for-industry-on-hypertension-indication-drug-labeling-for-cardiovascular-outcome-claims https://www.govinfo.gov/content/pkg/FR-2011-03-15/pdf/2011-5945.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims." This guidance is intended to assist applicants in developing labeling...  

Links from other tables